{"entity":{"id":"df522c7a-e48e-5f91-9ca6-42e06fe7e79e","name":"GLYNN MICHAEL","type":"Company","kind":"company","jurisdiction":"US","identifier":"sec:0001528924","risk":"LOW","flags":[],"registry_profile":null},"identity":{"linked_records":[],"also_known_in":[]},"ownership":{"direct_owners":[],"holdings":[{"role":"officer","share":null,"subsidiary":{"id":"aabad33f-5398-5580-80ed-e469622973b8","name":"SYNAGEVA BIOPHARMA CORP","type":"Company","kind":"company","identifier":"sec:0000911326"}},{"role":"officer","share":null,"subsidiary":{"id":"95e47b25-7575-5943-a2c4-15a6bd30c715","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","type":"Company","kind":"company","identifier":"sec:0001299130"}}],"ubo_chain":[]},"risk":{"level":"LOW","flags":[],"note":"Risk is a layer-1 signal (offshore-layering / connectivity heuristics) — an investigative lead, not a determination."},"financials":null,"sources":[],"access":{"tier":"free","note":"Free tier: identity, cross-source links, 1-hop subsidiaries, risk/sanctions, latest financials and provenance. The full multi-hop UBO chain, itemised assets (vessels/aircraft/securities/real estate) and financial history unlock with a paid API key or a one-off dossier — whiteintel.dev/pricing."},"source":"corpus"}